Cargando…
Complete versus culprit-vessel only revascularization in STEMI: An updated meta-analysis of randomized control trials
Autores principales: | Gupta, Kartik, Chopra, Lakshay, Salame, Ameen, Gharpure, Nitin, Prejean, Shane P., von Mering, Gregory, Al Solaiman, Firas, Eudailey, Kyle, Bajaj, Navkaranbir S., Ahmed, Mustafa I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191581/ https://www.ncbi.nlm.nih.gov/pubmed/32373708 http://dx.doi.org/10.1016/j.ijcha.2020.100481 |
Ejemplares similares
-
Effect of immunomodulation on cardiac remodelling and outcomes in heart failure: a quantitative synthesis of the literature
por: Bajaj, Navkaranbir S., et al.
Publicado: (2020) -
Multi-vessel Versus Culprit-vessel-only PCI for STEMI: Where Does the Jury Stand?
por: Almas, Talal, et al.
Publicado: (2021) -
Culprit lesion-only versus complete revascularization in patients with STEMI: Lessons learned from PRAMI, CvLPRIT, and DANAMI-3 PRIMULTI
por: Hassan, Ahmed, et al.
Publicado: (2015) -
Does dual vs. triple antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation lower the risk of bleeding at the cost of increased risk of ischemic events?()
por: Gupta, Kartik, et al.
Publicado: (2019) -
Percutaneous Intervention in ST-Elevation Myocardial Infarction:
Culprit-only or Complete Revascularization?
por: Osório, Ana Paula Susin, et al.
Publicado: (2017)